VF
HRMY icon

Virtu Financial’s Harmony Biosciences HRMY Stock Holding History

Virtu Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,618
Closed -$479K – 1749
2023
Q3 		$479K Buy
+14,618
New +$507K 0.05% 366
2023
Q2 		– Sell
-39,067
Closed -$1.28M – 1723
2023
Q1 		$1.28M Buy
+39,067
New +$1.78M 0.14% 147
2022
Q3 		– Sell
-4,207
Closed -$205K – 1922
2022
Q2 		$205K Sell
4,207
-16,499
-80% -$743K 0.02% 756
2022
Q1 		$1.01M Buy
+20,706
New +$844K 0.07% 222

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Virtu Financial's HRMY Position: Q4 2023 in Review

Virtu Financial sold out of Harmony Biosciences (HRMY) in Q4 2023, closing a stake of 14,618 shares — an estimated $479K sold.

Virtu Financial first reported a position in HRMY in Q1 2022 and held it in 4 quarters. The position peaked at $1.28M in Q1 2023. 221 funds tracked by Wall St. Rank hold HRMY as of Q4 2023.

  • Virtu Financial reported no remaining Harmony Biosciences position as of Q4 2023 after selling out during the quarter.
  • Virtu Financial sold 14,618 Harmony Biosciences shares in Q4 2023, an estimated $479K.
  • Virtu Financial first reported a position in Harmony Biosciences in Q1 2022 and held it in 4 quarters.
  • Virtu Financial's Harmony Biosciences position peaked at $1.28M in Q1 2023.
  • 221 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.